ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2085

T Cell-Mediated Murine Antigen-Induced Arthritis Is Resistant to Transgenic Disruption of Glucocorticoid Signaling in Osteoblasts and Osteocytes in Vivo

Cornelia M. Spies1, Edgar Wiebe1, Jinwen W. Tu2, Aiqing Li2, Timo Gaber1, Dörte Huscher1, Markus J. Seibel2, Hong Zhou2 and Frank Buttgereit3, 1Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany, 2Bone Research Program, ANZAC Research Institute, The University of Sydney, Concord, Australia, 3Charité - Universitätsmedizin Berlin, Berlin, Germany

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Animal models, glucocorticoids, osteoblasts and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis: Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: The role of endogenous glucocorticoids (GC) in, and their contribution to the susceptibility and severity of rheumatoid arthritis remains inconclusive. We previously demonstrated that disruption of GC signaling in osteoblasts results in attenuation of arthritis in the antibody-mediated mouse model of K/BxN serum-induced arthritis (Buttgereit et al., Arthritis Rheum 2009). The aim of this study was to test whether GC-dependent osteoblast effects have a similar impact on the T cell-mediated model of antigen-induced arthritis (AIA).

Methods: GC signaling in osteoblasts was disrupted by transgenic overexpression of 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) under the control of a type I collagen promoter. Arthritis was induced by intra-articular injection of mBSA into one knee joint of pre-immunised 11-week old male transgenic mice (tg) and their wild-type (WT) littermates. Controls received PBS. Knee joint swelling was assessed continuously for 14 days until the mice were sacrificed. The mice were examined by histology, histomorphometry, and micro-CT. In a part of the animals, arthritis was prolonged through three weekly repeated intravenous injections of mBSA until day 28. Statistical analysis was performed by repeated measures analysis.

Results: Acute and significant arthritis developed in both 11β-HSD2-tg and WT mice with maximum knee joint swelling on day 1 and abatement thereafter, with no significant difference in knee joint swelling between tg (n=14) and WT mice (n=17). Histological indices of inflammation, cartilage damage and bone erosion of WT and tg mice, respectively, accordingly showed no differences. Bone turnover and bone volume measured at the contralateral knee remained unchanged. In the prolonged AIA model with repeated intravenous antigen boosts, a significant arthritis with flares on days 7, 14 and 21 was achieved, but also without significant differences between tg mice (n=7) and their WT littermates (n=8) and corroborating histological findings.

Conclusion: In contrast to K/BxN serum-induced arthritis, murine antigen-induced arthritis is resistant to disruption of GC signaling in osteoblasts. This suggests that osteoblasts do not modulate the T cell-mediated inflammatory response but the antibody-mediated inflammatory response (complement, Fc receptors, neutrophils, monocytes/macrophages) via a GC-dependent pathway.


Disclosure:

C. M. Spies,
None;

E. Wiebe,
None;

J. W. Tu,
None;

A. Li,
None;

T. Gaber,
None;

D. Huscher,
None;

M. J. Seibel,
None;

H. Zhou,
None;

F. Buttgereit,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/t-cell-mediated-murine-antigen-induced-arthritis-is-resistant-to-transgenic-disruption-of-glucocorticoid-signaling-in-osteoblasts-and-osteocytes-in-vivo/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology